Literature DB >> 17291608

Comparison of angiographic patterns of in-stent restenosis between sirolimus- and paclitaxel-eluting stent.

Chang-Bum Park1, Myeong-ki Hong, Young-Hak Kim, Duk-Woo Park, Ki-Hoon Han, Cheol Whan Lee, Duck-Hyun Kang, Jae-Kwan Song, Jae-Joong Kim, Seong-Wook Park, Seung-Jung Park.   

Abstract

BACKGROUND: Angiographic pattern of in-stent restenosis (ISR) after drug-eluting stent (DES) implantation was known to be different to that after bare metal stent (BMS) implantation. But the different angiographic patterns of ISR and its prognosis between sirolimus-eluting stent (SES) and paclitaxel-eluting stent (PES) has not been properly addressed in large scale studies. OBJECTIVES AND METHODS: We evaluated the angiographic pattern of ISR and their subsequent clinical outcomes in 177 ISR lesions of 163 consecutive patients previously treated with SES (n=97) or PES (n=80) from February 2003 to April 2005.
RESULTS: In angiographic ISR pattern, diffuse ISR was more common in PES implantation (SES vs PES; 23.7% vs 48.7%, p=0.001) mainly because of higher incidence of diffuse intrastent ISR (8.2% vs 33.8%, p<0.001, respectively) whereas focal ISR was more common in SES implantation (76.3% vs 51.3%, p=0.001, respectively) mainly because of higher incidence of focal margin ISR (27.8% vs 2.5%, p<0.001, respectively). Among 177 ISR lesions, clinically driven target lesion revascularization (TLR) was performed in 53.6% in SES implantation and 56.3% in PES implantation (p=0.725).
CONCLUSION: Angiographic pattern of ISR differed after SES and PES implantation, but their subsequent TLR rate was similar to both types of DES.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17291608     DOI: 10.1016/j.ijcard.2006.10.014

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  4 in total

1.  Long-term angiographic outcomes of post-sirolimus-eluting stent restenosis in Japanese patients.

Authors:  Nobuyuki Miyai; Noriyuki Kinoshita; Keisuke Oota; Takeshi Yamada; Reo Nakamura; Hidekazu Irie; Tetsuo Hashimoto; Shyunichi Tamaki; Hiroaki Matsubara
Journal:  Heart Vessels       Date:  2010-10-27       Impact factor: 2.037

2.  Comparison of full lesion coverage versus spot drug-eluting stent implantation for coronary artery stenoses.

Authors:  Seunghwan Kim; Kyeong Ho Yun; Woong Chol Kang; Dong-Ho Shin; Jung-Sun Kim; Byeong-Keuk Kim; Young-Guk Ko; Donghoon Choi; Yangsoo Jang; Myeong-Ki Hong
Journal:  Yonsei Med J       Date:  2014-04-01       Impact factor: 2.759

3.  Targeting AGGF1 (angiogenic factor with G patch and FHA domains 1) for Blocking Neointimal Formation After Vascular Injury.

Authors:  Yufeng Yao; Zhenkun Hu; Jian Ye; Changqing Hu; Qixue Song; Xingwen Da; Yubin Yu; Hui Li; Chengqi Xu; Qiuyun Chen; Qing Kenneth Wang
Journal:  J Am Heart Assoc       Date:  2017-06-25       Impact factor: 5.501

4.  Mid-Term Follow-Up of Drug-Eluting Stenting for In-Stent Restenosis: Bare-Metal Stents versus Drug-Eluting Stents.

Authors:  Negar Faramarzi; Mojtaba Salarifar; Seyed Ebrahim Kassaian; Ali Mohammad Haji Zeinali; Mohammad Alidoosti; Hamidreza Pourhoseini; Ebrahim Nematipour; Mohammad Reza Mousavi; Hamidreza Goodarzynejad
Journal:  J Tehran Heart Cent       Date:  2013-01-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.